Cargando…
Real-life outcomes of subthreshold laser therapy for diabetic macular edema
BACKGROUND: Diabetic macular edema (DME) is a major cause of visual impairment and its treatment is a public health challenge. Even though anti-angiogenic drugs are the gold-standard treatment, they are not ideal and subthreshold laser (SL) remains a viable and promising therapy in selected cases. T...
Autores principales: | Passos, Renato M., Malerbi, Fernando K., Rocha, Marindia, Maia, Maurício, Farah, Michel E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796544/ https://www.ncbi.nlm.nih.gov/pubmed/33422155 http://dx.doi.org/10.1186/s40942-020-00268-3 |
Ejemplares similares
-
Commentary: Subthreshold micropulse yellow laser in diabetic macular edema
por: Bansal, Mayank
Publicado: (2020) -
Subthreshold Micropulse Laser for Diabetic Macular Edema: A Review
por: Sabal, Barbara, et al.
Publicado: (2022) -
Diabetic Macular Edema Treated with 577-nm Subthreshold Micropulse Laser: A Real-Life, Long-Term Study
por: Frizziero, Luisa, et al.
Publicado: (2021) -
Comparison of different settings for yellow subthreshold laser treatment in diabetic macular edema
por: Chhablani, Jay, et al.
Publicado: (2018) -
Subthreshold Micropulse Laser Modulates Retinal Neuroinflammatory Biomarkers in Diabetic Macular Edema
por: Frizziero, Luisa, et al.
Publicado: (2021)